3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide has been researched along with batimastat in 2 studies
| Studies (3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide) | Trials (3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide) | Recent Studies (post-2010) (3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide) | Studies (batimastat) | Trials (batimastat) | Recent Studies (post-2010) (batimastat) |
|---|---|---|---|---|---|
| 6 | 0 | 0 | 347 | 6 | 56 |
| Protein | Taxonomy | 3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide (IC50) | batimastat (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.025 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.025 | |
| Interstitial collagenase | Homo sapiens (human) | 0.3158 | |
| Low affinity immunoglobulin epsilon Fc receptor | Homo sapiens (human) | 0.1 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 0.3029 | |
| Stromelysin-1 | Homo sapiens (human) | 1.1205 | |
| Matrilysin | Homo sapiens (human) | 3.5012 | |
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.0066 | |
| Neutrophil collagenase | Homo sapiens (human) | 0.7 | |
| Metabotropic glutamate receptor 5 | Rattus norvegicus (Norway rat) | 1.2 | |
| Collagenase 3 | Homo sapiens (human) | 0.005 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.025 | |
| Matrix metalloproteinase-14 | Homo sapiens (human) | 0.5715 | |
| Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) | 0.0149 | |
| Snake venom metalloproteinase BaP1 | Bothrops asper (terciopelo) | 1.2 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.025 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.025 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailey, S; Bolognese, B; Buckle, DR; Faller, A; Jackson, S; Louis-Flamberg, P; Marshall, LA; Mayer, RJ; McCord, M; Smith, DG | 1 |
| Epps, DE; Laborde, AL; Petzold, GL; Poorman, RA; Stuchly, CW; Van Drie, JH | 1 |
2 other study(ies) available for 3-((benzyl)(methylaminocarbonyl)methylaminocarbonyl)n-hydroxy-5-methylhexanamide and batimastat
| Article | Year |
|---|---|
Selective inhibition of low affinity IgE receptor (CD23) processing.
Topics: Hydroxamic Acids; Phenylalanine; Protease Inhibitors; Protein Processing, Post-Translational; Receptors, IgE; Structure-Activity Relationship; Thiophenes | 1998 |
The constituent tryptophans and bisANS as fluorescent probes of the active site and of a secondary binding site of stromelysin-1 (MMP-3).
Topics: Acrylamides; Anilino Naphthalenesulfonates; Binding Sites; Catalytic Domain; Fluorescence Polarization; Fluorescent Dyes; Hydroxamic Acids; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Models, Chemical; Phenylalanine; Protease Inhibitors; Protein Binding; Pyrazines; Spectrometry, Fluorescence; Sulfonamides; Thiophenes; Tryptophan | 1998 |